ATTD 2024 - Interview with Dr Trang Ly, Omnipod Senior VP and Medical Director

In this interview at ATTD 2024, Rob, interviews Trang Ly, the Senior Vice President and Medical Director at Insulet. They discuss the latest technology in diabetes care, focusing on the Omnipod 5 system and its integration with sensors. Trang shares insights on the benefits of automated insulin delivery, customization, and the future of diabetes care. They also touch on trial periods for the Omnipod system and the importance of raising awareness about diabetes technology.
00:00 Revolutionizing Diabetes Care with Omnipod 5: An Inside Look at Insulet's Latest Innovations
03:27 The Future of Omnipod Technology
08:15 Gratitude and Appreciation for ATTD interview
Topics discussed:
Role of a Senior Medical Adviser:
Trang explains her role as a medical director at Insulet, focusing on sharing clinical benefits of technology with doctors to enhance patient care.
Omnipod 5 and Sensor Integration:
Trang discusses the features of Omnipod 5, including its tubeless design and the ability to customize glucose control through an automated insulin delivery system.
She highlights the integration of sensors with Omnipod 5, mentioning the use of the Freestyle Libre 2 plus sensor for improved care.
Future of Diabetes Care:
Trang expresses excitement about expanding sensor connectivity and providing automated insulin delivery to more patients worldwide.
She emphasizes the benefits of technology like smart pens and patch pumps in enhancing diabetes management and improving time in range for patients.
Trial Periods and Patient Flexibility:
The conversation touches on offering trial periods for Omnipod systems to increase awareness and allow patients to experience the benefits firsthand.
Trang explains the strategy behind trial periods, emphasizing the freedom and flexibility the Omnipod system offers to users.
Importance of Awareness and Patient Choice:
Trang discusses the significance of raising awareness about diabetes technology and ensuring patients have access to innovative care options.
She highlights the high coverage of Omnipod through commercial insurance plans, promoting patient choice and flexibility in managing their diabetes.
Key takeaways and lessons:
Automated insulin delivery systems like Omnipod 5 offer customization and improved glucose control for patients with diabetes.
Integration of sensors with insulin delivery systems enhances care and provides more options for patients worldwide.
Offering trial periods allows patients to experience the benefits of new technology firsthand and make informed choices about their diabetes management.
Raising awareness about diabetes technology is crucial in ensuring patients have access to innovative care options and can make informed decisions about their health.
References:
Insulet: www.insulet.com/
Omnipod: www.omnipod.com/
Freestyle Libre: www.freestylelibre.us/

[@GrantLaret]

Can Omnipod please consider South Africa as a market !

[@jonmoore5909]

This video is just pure corporate speak. Just ask where the iPhone app is. Why does it take Insulet years to come up with an app that Tandem gets done in half the time? Why does it take years for Omnipod 5 to support G7? I wish these diabetes influencers would actually ask tougher questions to these reps instead of putting out puff pieces on behalf of the corporations. If you want to benefit the diabetics community then help us hold these companies accountable and push them accelerate their innovation.